https://www.selleckchem.com/pr....oducts/dual-specific
Treatment for rectal cancer is very standardized. However, for total mesorectal excision (TME) with positive margins at microscopic pathological examination (classified R1 ), there is no consensus regarding management. The objective of this update was, through a review of the literature, to identify the most suitable management to improve overall survival and/or recurrence-free survival after R1 TME for rectal cancer. Published national quality guidelines and original studies were searched
Like
Comment
Share
